Author

B. W. McColl

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Assay:proteomics· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Organism:human· 1 Assay:metagenomics· 1 Organism:mouse· 1

Frequent Co-Authors

C. J. Smith· 2 shared L. McCulloch· 2 shared S. M. Allan· 2 shared A. J. Harris· 1 shared A. Malbon· 1 shared J. R. Grainger· 1 shared M. J. D. Daniels· 1 shared M. Younas· 1 shared

Activity by Year

2019-2021 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

C. J. Smith

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivDec 16, 2021

Treatment with IgM-enriched intravenous immunoglobulins (IgM-IVIg) enhances clearance of stroke-associated bacterial lung infection

L. McCulloch, A. J. Harris, A. Malbon…·B. W. McColl

This study shows that IgM-enriched intravenous immunoglobulin (IgM-IVIg) improves bacterial clearance and reduces lung inflammation after stroke.

DOI 10.1111/imm.13553

mouseproteomics

𝕏 PostBluesky

ImmunologybioRxivMar 26, 2019

Interleukin-1 receptor antagonist treatment in acute ischaemic stroke does not alter systemic markers of anti-microbial defence

L. McCulloch, S. M. Allan, C. J. Smith, B. W. McColl

This study examines whether IL-1Ra treatment in acute ischaemic stroke affects systemic anti-microbial defenses, finding no significant differences in immunoglobulin and complement levels between treated and placebo groups.

DOI 10.12688/f1000research.19308.1

humanproteomics

𝕏 PostBluesky